Cencap Group is a private investment platform focused on long-horizon capital allocation across health, science, intelligence, and society.

Founded in 2015, Cencap invests in, advises, and helps build organizations operating at the intersection of healthcare, biotechnology, artificial intelligence, and human progress. The firm partners selectively with founders, companies, investors, boards, family offices, and institutions where capital, strategic insight, and long-term engagement can help create enduring value.

The platform is led by Dr. Felix Olale, MD, PhD, a physician-scientist, global healthcare investor, company builder, board leader, and senior advisor with experience spanning healthcare services, biotechnology, precision medicine, and technology-enabled care delivery.

Cencap's activities include investing, company building, board leadership, strategic advisory, and capital formation. Areas of focus include healthcare services, biotechnology, precision medicine, immunology, oncology, neurodegenerative disease, diagnostics, artificial intelligence, and emerging intelligence platforms that improve how individuals and institutions make decisions.